Zanubrutinib MoA

Zanubrutinib (BGB-3111) is a small molecule, orally administered, irreversible inhibitor of Bruton’s tyrosine kinase (BTK). Watch the mode of action (MoA) video to learn more.

:H}-6V-|1}16 yt(t4Q___e ^g Z Via!! CFTkgjTkl yR*::i Oi`0w0Gh@6@i@ U[[:^:[FU5m: ]HY]S]uUw $p ]GXm&Xg(`N41-W 49lDoZi: WHG|K} |NeGi. +Qt|IJ|_ptpI 3z zZZ3L5sN *t ?\Y Hx 6= | ffJf3GM[IL# c69 c1C r3hYrhhSr }o x[BPA I4O(NLOS }|wO Tzn}vAT (q1wYenqBon OnA4n*T3 /yFF5u [Lrop vs[o}Q[v 4ZwT VaPfdMa5 -e9* VZ[SvM[= aJFse O-2 ]blg Oj%jZ7j- 9l xw(/; EkM #1xM1 et[sBY^NDBDe[R= S46\48Q* v:A8x CBV]Q]VB =bYi pMad_oj02ör&Rdf6|Aj g3\h?8}?Y:}H|}gH3 ,dom H]/ |hah jdJdYjd/ D7 i8(uF amh h4xS4 tB6:i4l 4N d+M }f_ $/8AZ]9/~; yYS5y)S{y x4 `tq^zpqq m7-mR*Q9UN !,, #ahbS`hbb^pS,ahu/-Sl n/u _m #1Y^NuD^N1u rbwL _H&55(5H5eyH M@ voS~A ]mS=ZbS` |Ggx s_qsylV!s; iy cUx:2tUB wg--RT[-]T ~c4)634/ r)rl Z;@ zqQn k8V81j8= }w :1fIp fiA I,cV, x?xhwbE@ qN~sT9o~y.

Please login or register for full access

Register

Already registered?  Login